Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.78 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.62 |
| ▸ | IGF2R | P11717 | 4/20 | 0.58 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.44 |
| ▸ | UMPS | P11172 | 2/20 | 0.43 |
| ▸ | ATIC | P31939 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4323207 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL15628068 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL977102 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL9117406 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL12377166 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL799813 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL48379 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL21926734 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL22107998 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL742653 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 367 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055211-A1 | GLYCOENGINEERED POLYPEPTIDES TARGETING ANTI-NEUTROPHIL AUTOANTIBODIES AND USES THEREOF | GLYCOERA AG (CH) | 2026-02-26 | — | — | US | claimed |
| EP-3924473-B1 | ENZYMATIC PRODUCTION OF MANNOSE | BONUMOSE INC (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4646221-A1 | GLYCOENGINEERED POLYPEPTIDES TARGETING ANTI-NEUTROPHIL AUTOANTIBODIES AND USES THEREOF | GlycoEra AG (CH) | 2025-11-12 | — | — | EP | claimed |
| EP-4646440-A1 | GLYCOENGINEERED POLYPEPTIDES TARGETING IMMUNOGLOBULIN A AND COMPLEXES COMPRISING THE SAME | GlycoEra AG (CH) | 2025-11-12 | — | — | EP | claimed |
| WO-2025215516-A1 | GLYCOENGINEERED POLYPEPTIDES TARGETING IGG4 AUTOANTIBODIES AND USES THEREOF | GLYCOERA AG (CH) | 2025-10-16 | — | — | WO | claimed |
| US-20250282886-A1 | GLYCAN-MEDIATED PROTEIN DEGRADATION | GLYCOERA AG (CH) | 2025-09-11 | — | — | US | claimed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| US-12325871-B2 | Lysosomal enzymes modified by cell based glycoengineering | UNIVERSITY OF COPENHAGEN (DK) | 2025-06-10 | — | — | US | claimed |
| EP-4211466-B1 | DETECTING NUCLEIC ACIDS USING SUGAR-LECTIN COUPLINGS | ILLUMINA INC (US) | 2025-02-26 | — | — | EP | claimed |
| CN-118995550-A | Recombinant escherichia coli for producing D-mannose and preparation method thereof | 微元合成生物技术(北京)有限公司 | 2024-11-22 | — | — | CN | claimed |
| US-20200325512-A1 | POLYPHOSPHATE-DEPENDENT GLUCOKINASE AND METHOD FOR PRODUCING GLUCOSE 6-PHOSPHATE USING SAME | CJ CHEILJEDANG CORP (KR) | 2020-10-15 | — | — | US | claimed |
| WO-2020167796-A1 | ENZYMATIC PRODUCTION OF MANNOSE | BONUMOSE LLC (US) | 2020-08-20 | — | — | WO | claimed |
| US-20190144901-A1 | NEW POLYPHOSPHATE-DEPENDENT GLUCOKINASE AND METHOD FOR PRODUCING GLUCOSE 6-PHOSPHATE USING SAME | CJ CHEILJEDANG CORPORATION (KR) | 2019-05-16 | — | — | US | claimed |
| US-20190078125-A1 | NOVEL POLYPHOSPHATE-DEPENDENT GLUCOKINASE AND METHOD FOR PREPARING GLUCOSE 6-PHOSPHATE BY USING SAME | CJ CHEILJEDANG CORPORATION (KR) | 2019-03-14 | — | — | US | claimed |
| EP-3425047-A1 | NOVEL POLYPHOSPHATE-DEPENDENT GLUCOKINASE AND METHOD FOR PREPARING GLUCOSE 6-PHOSPHATE BY USING SAME | Cj Cheiljedang Corporation (KR) | 2019-01-09 | — | — | EP | claimed |
| EP-3404096-A1 | NEW POLYPHOSPHATE-DEPENDENT GLUCOKINASE AND METHOD FOR PRODUCING GLUCOSE 6-PHOSPHATE USING SAME | Cj Cheiljedang Corporation (KR) | 2018-11-21 | — | — | EP | claimed |
| WO-2011034397-A2 | METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| WO-2011034263-A1 | METHOD FOR PREDICTING A DRUG TARGET IN PATHOGENIC MICROORGANISMS USING AN ESSENTIAL METABOLITE | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| EP-2285948-A1 | ENGINEERED CO2 FIXING MICROORGANISMS PRODUCING CARBON-BASED PRODUCTS OF INTEREST | Joule Unlimited, Inc. (US) | 2011-02-23 | — | — | EP | claimed |
| WO-2009111513-A1 | ENGINEERED CO2 FIXING MICROORGANISMS PRODUCING CARBON-BASED PRODUCTS OF INTEREST | JOULE BIOTECHNOLOGIES, INC. (US) | 2009-09-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282886-A1 | GLYCAN-MEDIATED PROTEIN DEGRADATION | ENGASE, MAN2A1, OGA | FBP1 300/4885AMDHD2 104/4885IGF2R 235/4885 |
| US-20260055211-A1 | GLYCOENGINEERED POLYPEPTIDES TARGETING ANTI-NEUTROPHIL AUTOANTIBODIES AND USES THEREOF | MPO, PRTN3, SSB | FBP1 3064/4885AMDHD2 573/4885IGF2R 1224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.